Ortho-Clinical Diagnostics Inc.
- UEI
- H7TKMH25XXJ4
- CAGE
- 03KD1
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Expired
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Raritan, NJ
JG5JF2JQJ121
-
Parent
Raritan, NJ
JG5JF2JQJ121
- SAM.gov registration date
- Website
- quidelortho.com
- Founded
- 1979
- Employees
- 5K-10K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $172 |
| FY2026 | $224,972 |
| FY2025 | $578,961 |
| FY2024 | $445,980 |
| FY2023 | $441,016 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Health Agency | $198,267 | |
| 2 | Department of Veterans Affairs | $33,126 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Ortho-Clinical Diagnostics Inc. is a for-profit medical equipment manufacturer and self-certified HUBZone joint venture headquartered in Rochester, New York. The company specializes in providing clinical diagnostic supplies, medical equipment, reagents, and testing services to various federal agencies, with a primary focus on medical diagnostics and laboratory solutions. Their product portfolio includes clinical chemistry analyzers, immunoassay systems, blood typing instruments, and related consumables that support medical testing and diagnostic capabilities across federal healthcare institutions.
Through federal contract awards, Ortho-Clinical Diagnostics Inc. has consistently provided a wide range of medical diagnostic products and services to multiple federal agencies, including the Department of Veterans Affairs, Defense Health Agency, Department of the Army Medical Command, and the Department of the Navy. Their contract awards have encompassed critical medical supplies such as chemistry and immunoassay reagent testing supplies, blood bank reagents, clinical diagnostic services, medical equipment maintenance, and specialized testing solutions. Most notably, the company has received significant contract awards like an $88.4 million Industrial Base Expansion project from the Air Force Materiel Command and numerous purchase orders ranging from $20,000 to over $1 million for medical diagnostic supplies. These contracts have consistently been awarded without specific set-aside designations and have supported medical testing programs across military treatment facilities, veterans' health networks, and federal medical centers.
In terms of federal grant awards, Ortho-Clinical Diagnostics Inc. has participated as a sub-grantee in collaborative research projects, most prominently in COVID-19 testing development. A notable example is their involvement in a sub-grant awarded by The Research Foundation for the State University of New York for a project titled "Disposable Photonics for Biomedical Assays: Rapid, Compact, Microfluidic Photonic Integrated Circuit-based COVID-19 Test." This project involved developing a robust antibody test platform with integrated photonic sensors, demonstrating the company's capacity to engage in advanced medical research and technology development alongside academic and research institutions.
Regarding federal contract Indefinite Delivery Vehicles (IDVs), Ortho-Clinical Diagnostics Inc. has secured multiple single-award IDVs that enable flexible procurement of medical supplies and services. A prominent example is a $1,052,500 IDV with the Department of the Army Medical Command for automated in vitro reagents, with a performance period from October 2020 to September 2023. Another notable IDV is a $74,766.90 contract with Veterans Integrated Service Network 6 for blood bank reagents, valid through September 2025. These IDVs allow federal agencies to efficiently order medical diagnostic supplies and services as needed, supporting the company's role as a critical supplier in federal healthcare infrastructure.
Quick answers
Is Ortho-Clinical Diagnostics Inc. registered in SAM.gov?
Ortho-Clinical Diagnostics Inc.'s SAM.gov registration expired on May 1, 2026.
How much has Ortho-Clinical Diagnostics Inc. received in federal contracts?
Federal contracts obligated $578,961 to Ortho-Clinical Diagnostics Inc. in fiscal year 2025 and $1,691,101 in fiscal years 2023 through 2027.
How does Ortho-Clinical Diagnostics Inc. rank among federal contractors?
Ortho-Clinical Diagnostics Inc. ranked #3 in PSC W066, #6 in PSC 6550 and #7 in NAICS 325413 in FY2025.
What is Ortho-Clinical Diagnostics Inc.'s most recent federal award?
Ortho-Clinical Diagnostics Inc.'s most recent federal contract award is Ortho clinical diagnostic supplies FY24 (15B50525P00000040), from Federal Medical Center Carswell (BOP), on January 31, 2025.
On GovTribe
See Ortho-Clinical Diagnostics Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors